A5K-20305-29498

3 vaccinations 3 coded responses 20 check-ins 2 free-text entries 3 call cases

Sex: Male
Age at first dose: 0-4
ZIP prefix: 024 / MA
Registered: 2022-07-03

Relationship: Child or adolescent in my care
Guardian: 9ZU-58707-05559
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2465527 (opens in a new window)	high	9 / 11	—	1 of 5 VAERS symptoms	same dose (3)	MA matches	2022-09-24 / 2022-09-28 / 2022-09-30 received 179 days before the last call	case 409294

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-03
Registered in v-safe
2022-07-03
Dose 1 — Pfizer-BioNTech
2022-07-03
Health check-in — day 0, dose 1, under 3
Feeling: Good · Site: Pain · Sleepiness, Irritability/crying

Under 3 check-in
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Site: Pain · Fever · Irritability/crying

Under 3 check-in
2022-07-06
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Site: Pain · Fever · Irritability/crying

Under 3 check-in
2022-07-09
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-10
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-17
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-24
Dose 2 — Pfizer-BioNTech
2022-07-24
Health check-in — day 0, dose 2, under 3
Feeling: Good · Site: Pain · Sleepiness, Irritability/crying

Under 3 check-in
2022-07-25
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Site: Pain · Irritability/crying, Loss of appetite

Under 3 check-in
2022-07-26
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Loss of appetite

Under 3 check-in
2022-08-01
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-07
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-22
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-05
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-24
Dose 3 — Pfizer-BioNTech
2022-09-24
Health check-in — day 0, dose 3, under 3
Feeling: Fair · Site: Pain · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to do your normal daily activities

Under 3 check-in
2022-09-25
Health check-in — days 1–6 daily, dose 3, under 3
Feeling: Fair · Site: Pain · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school

Under 3 check-in
2022-09-29
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Ear infection, Office visit — Feeling: Fair · Fever · Irritability/crying · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Ear infection - diagnosed by MD

MedDRA releases: 2024-11 · check-in free text available
2022-09-29
Report sent to call center — days 1–6 daily, dose 3, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-09-30
Call 1 — Left Voicemail
2022-09-30
Call successful
Completed over the phone
2022-10-03
Health check-in — day 7, dose 3, under 3
Feeling: Good · None

Under 3 check-in
2022-10-08
Health check-in — day 14, dose 3, under 3
Feeling: Good

Under 3 check-in
2022-10-17
Survey response — day 21, dose 3, under 3
MedDRA: Ear infection, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Double ear infection and RSV

MedDRA releases: 2024-11 · check-in free text available
2022-10-17
Report sent to call center — day 21, dose 3, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-10-17
Call 2 — Left Voicemail
2023-03-27
Survey response — 6 months, dose 3, under 3
MedDRA: Immunoglobulin therapy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-27
Report sent to call center — 6 months, dose 3, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-28
Call 1 — Left Voicemail
2023-03-28
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-03	Pfizer-BioNTech	No
2	2022-07-24	Pfizer-BioNTech	No
3	2022-09-24	Pfizer-BioNTech	No

Call center

3 call center cases

1 successful · 2 unsuccessful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 3, under 3

2022-09-29

Systemic reaction (other): Ear infection - diagnosed by MD

Release 12 (Under 3) — day 21, dose 3, under 3

2022-10-17

Symptoms: Double ear infection and RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ear infection	·	·	✓
SD	Immunoglobulin therapy	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SRO	Ear infection	·	·	✓
SRO	Office visit	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release